EUVIMED · CrossrefJournal
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
ISSN 2405-5794 · Elsevier BV
Latest articles
GeneXpert negativity during anti-tuberculosis treatment and drug susceptibility patterns among tuberculosis patients in displaced populations in Northwest Ethiopia: A prospective longitudinal study
Association of pyrazinamide resistance to treatment outcome in adult drug-resistant tuberculosis patients: a systematic review and meta-analysis
Diagnostic yield and incremental case detection of Urine LF-LAM among adults and children with advanced HIV disease in Nigeria: a prospective programmatic evaluation
COPD-like phenotypes after pulmonary tuberculosis: Structural, functional and biological pathways within post-tuberculosis lung disease
Proportions of M. Intracellulare and M. Avium among non-tuberculous mycobacteria isolates in China: A Systematic review and Meta-Analysis
Therapeutic drug monitoring of first-line anti-tuberculosis drugs: impact of dose modification on plasma drug concentrations in pulmonary and extrapulmonary tuberculosis
Development of a diagnostic nomogram for tuberculous pleural effusion
Prevalence of Long COVID in Mycobacterium tuberculosis-exposed groups
Host genetic polymorphisms, immune response, and susceptibility to pleural tuberculosis: A systematic review
The critical link between clinical risk stratification and pharmacovigilance in tuberculosis therapy: implications for rifampicin-induced cholestatic jaundice
Comment on “Prevalence and risk factors associated with rifampicin-induced cholestasis jaundice among tuberculosis patients in high-incidence setting: A retrospective cohort study”
Evaluation of the laboratory performance of MolecuTech®REBA MTB-MDR kit for the detection of multidrug resistant tuberculosis
Epidemiology of extrapulmonary tuberculosis, Alameda County, California, 2010–2021
Comments on “Prevalence and risk factors associated with rifampicin-induced cholestasis jaundice among tuberculosis patients in high-incidence setting: a retrospective cohort study”
Analysis of the differential clinical characteristics of tuberculosis and nontuberculous mycobacterial diseases among AIDS patients
Illicit substance use and its impact on tuberculosis care engagement: A systematic review and Meta-analysis of prevalence
Efficacy and safety of an intravenous amikacin-containing regimen as initial therapy in Mycobacterium avium complex pulmonary disease
Acetylator status-guided rapid reintroduction of isoniazid in tuberculosis patients with drug-induced hepatotoxicity
Real-world challenges of 4-month rifapentine-moxifloxacin TB regimen: High hyperbilirubinemia in Thailand
A diagnostic nomogram for tuberculous pleural effusion: Methodological considerations
Performance of the BACES model in a Dutch cohort with nontuberculous mycobacterial pulmonary disease
Challenges in tuberculosis screening before TNF-α inhibitors: A case report highlighting gaps in current practice
Private sector engagement in tuberculosis detection: a bibliometric analysis
Serum tuberculosis biomarkers and their association with clinical characteristics among hospitalized adults living with HIV in Uganda
Tuberculin responsiveness as a surrogate prognostic marker in hospitalized HIV-infected patients with tuberculosis in a resource-limited setting
Knowledge, attitudes, and perceived barriers to tuberculosis care among patients and household contacts in Wolisso District, Oromia Region, Ethiopia
Public transport: the missing link in tuberculosis control in Somalia
Developing an integrated medication event monitoring system and smartphone-based ecological momentary assessment delivery platform to identify real-time factors influencing TB treatment adherence in South Africa
Lung ultrasound and the interstitial syndrome in tuberculosis endemic regions: illustrated insights from diverse clinical settings
Pretomanid therapeutic drug monitoring and treatment of a pediatric patient with multidrug-resistant tuberculosis
EUVIMED